The Emory Neuromodulation and Technology Innovation Center (ENTICe) has received a second $100,000 gift from Florida-based Axiom Bank. The donation will support research aimed at developing new treatments for neurological and psychiatric conditions such as epilepsy, Parkinson’s disease and depression.

ENTICe is a collaborative effort between the Emory departments of neurology, neurosurgery, and psychiatry and behavioral sciences in partnership with scientists and biomedical engineers from Georgia Tech, to facilitate research and technical investigation to solve hurdles and develop new ideas to improve patient outcomes.

"One of the focuses of ENTICe’s Translational Neuroengineering Laboratory is regeneration of the nervous system to treat situations in which there is damage from neurodegenerative disorders, stroke, brain injury, and other problems," says Robert E. Gross, MD, PhD, director and co-founder of ENTICe and professor of neurosurgery, neurology, biomedical engineering and neuroscience at Emory University School of Medicine.

Recent research by the ENTICe team led to the development of a novel gene therapy treatment that increases the growth of brain neurons.

"This generous donation from Axiom Bank will drive this exciting project forward, allowing us to apply our novel gene therapy in models of clinical situations such as Parkinson’s disease and glaucoma. It will also help support a graduate student on this project," adds Gross.

Headquartered in Central Florida, Axiom Bank is a community bank committed to addressing the needs of people even beyond its home state.

"Axiom Bank is proud to support noble causes, such as Emory, in our home state of Florida and beyond," says Dan Davis, President and CEO of Axiom Bank. "It is our hope that this donation to ENTICe enables Emory to continue its important work in the field of brain heath, and we look forward to supporting this incredible organization in the future."

Axiom Bank is a Member FDIC and an Equal Housing Lender.